Search for: [Abstract = "The purpose of investigation was to study of microbiological recommendations for the diagnostic and therapeutical treatment in the patients with hospital\- acquired pneumonia from the Anesthesiology and Intensive Care Unit of Rydygier’s hospital in Cracow. The investigation was conducted in a group of 36 patients, consisting of 26 males \(72,2%\) and 10 females \(27,8%\) with clinically recognized pneumonia. HAP was microbiologically confirmed in the group of 31 patients, on the base of isolation from endotracheal aspirate bacteria in concentration of ≥106 CFU\/ml. The most frequent isolated aetiologic agents of pneumonia were Gram\- negative non\- fermenting bacilli\: Pseudomonas aeruginosa and Acinetobacter baumannii strains. Isolated in the pathological concentration P. aeruginosa strains demonstrated low Carbapenems sensitivity \(Imipenem, Meropenem\), respectively 27,3% and 31%. High activity in vitro, revealed Piperacillin\/ Tazobactam, which could be an alternative antimicrobial drug in the therapy of HAP due to P. aeruginosa strains, as well as new, registered in Poland, Carbapenems, for example Doripenem. Among Acinetobacter baumannii strains, which were isolated at the concentration of ≥106 CFU\/ml, noticed high resistance to ciprofloxacin \(97%\), which was often applied in the conjugate therapy. There is desirable to remove chemoterapeutic and to implement diverse antibiotic, for"]
